Genelux (GNLX) Common Equity (2022 - 2026)
Genelux's Common Equity was $22.92 million in Q1 2026, down 23.2% from $29.85 million a year earlier but up 98.6% from the prior quarter.
Powered by 
Analysis
Genelux (GNLX) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Genelux came in at $11.54 million, down 56.1% from FY2024.
- In earlier years, Common Equity was $26.27 million in FY2024 (+34.9%), $19.47 million in FY2023 and -$35.78 million in FY2022.
- Quarterly Common Equity has moved between -$35.78 million (Q4 2022) and $37.67 million (Q2 2024) over five years.
- Compared with a year earlier, Common Equity has declined for four straight quarters, with growth averaging 10.0% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 460.5%); the worst was Q4 2025 (a decline of 56.1%).
- Per Business Quant data, GNLX's Common Equity in the three quarters before Q1 2026 was $11.54 million (Q4 2025), $18.59 million (Q3 2025) and $23.9 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Genelux | 91.17 Mn | 29.45 Mn | - | 22.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 22.92 Mn |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | 18.59 Mn |
| Jun 30, 2025 | 23.90 Mn |
| Mar 31, 2025 | 29.85 Mn |
| Dec 31, 2024 | 26.27 Mn |
| Sep 30, 2024 | 33.09 Mn |
| Jun 30, 2024 | 37.67 Mn |
| Mar 31, 2024 | 15.08 Mn |
| Dec 31, 2023 | 19.47 Mn |
| Sep 30, 2023 | 24.03 Mn |
| Jun 30, 2023 | 22.26 Mn |
| Mar 31, 2023 | 2.69 Mn |
| Dec 31, 2022 | -35.78 Mn |
| Sep 30, 2022 | -32.33 Mn |
API Access
Genelux Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();